Literature DB >> 26966835

Oral Fluoroquinolones, Retinal Detachments, and Claims Database Studies.

Brian L VanderBeek1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26966835      PMCID： PMC4879681          DOI： 10.1001/jamaophthalmol.2016.0240

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN： 2168-6165            Impact factor:   7.389


× No keyword cloud information.
  5 in total

1.  Association between recent use of fluoroquinolones and rhegmatogenous retinal detachment: a population-based cohort study.

Authors:  Shu-Chen Kuo; Yung-Tai Chen; Yi-Tzu Lee; Nai-Wen Fan; Shih-Jen Chen; Szu-Yuan Li; Chia-Jen Liu; Te-Li Chen; Tzeng-Ji Chen; Chang-Phone Fung
Journal:  Clin Infect Dis       Date:  2013-10-28       Impact factor: 9.079

2.  Oral fluoroquinolones and the risk of retinal detachment.

Authors:  Mahyar Etminan; Farzin Forooghian; James M Brophy; Steven T Bird; David Maberley
Journal:  JAMA       Date:  2012-04-04       Impact factor: 56.272

3.  Risk of retinal tear or detachment with oral fluoroquinolone use: a cohort study.

Authors:  Kian Eftekhari; Devon H Ghodasra; Kevin Haynes; Jinbo Chen; John H Kempen; Brian L VanderBeek
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-04-22       Impact factor: 2.890

4.  Association between oral fluoroquinolone use and retinal detachment.

Authors:  Björn Pasternak; Henrik Svanström; Mads Melbye; Anders Hviid
Journal:  JAMA       Date:  2013-11-27       Impact factor: 56.272

5.  Exposure to oral fluoroquinolones and the risk of retinal detachment: retrospective analyses of two large healthcare databases.

Authors:  Daniel Fife; Vivienne Zhu; Erica Voss; Grace Levy-Clarke; Patrick Ryan
Journal:  Drug Saf       Date:  2014-03       Impact factor: 5.606
  5 in total
  1 in total

1.  Systemic quinolones and risk of retinal detachment III: a nested case-control study using a US electronic health records database.

Authors:  Mohamed Kadry Taher; James A G Crispo; Yannick Fortin; Ryan Moog; Douglas McNair; Lise M Bjerre; Franco Momoli; Donald Mattison; Daniel Krewski
Journal:  Eur J Clin Pharmacol       Date:  2022-03-15       Impact factor: 3.064
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.